Automated Variable Pattern Insufflator Device (AVPI) for the Acute Treatment of Migraine

  • STATUS
    Recruiting
  • participants needed
    80
  • sponsor
    Nocira, LLC
Updated on 18 January 2022
headache
acute treatment
episodic migraine
acute migraine

Summary

Randomized, sham-controlled, double-blind study for acute migraine attacks. Randomized to active treatment and sham treatment arms for the first treatment. Optional second active treatment. Follow up at 0, 2 and 24 hours post-treatment.

Description

Randomized, sham-controlled, double-blind study for acute migraine attacks.

Treatment Phase:

60 days to present at clinic for treating up to 2 migraines (at least 48 hours apart). First treatment is randomized between active treatment and sham treatment. Second optional treatment is open-label.

Post-Treatment Follow-up Phase:

  • 24 hours after initiating treatment, for each of up to two migraine treatments, for conducting post-treatment follow-up assessments of migraine symptoms.
  • 30, 60, and 90 days following the first migraine treatment for migraine diary assessments (and MIDAS assessment at 90 days)

Collection of migraine diaries at 30, 60, & 90 days post enrollment. Collection of MIDAS data at 60 and 90 days post treatment.

Details
Condition Migraine, Migraine (Pediatric), Migraine (Adult), Primary Stabbing Headache, Migraine and Cluster Headaches, Migraine (Adult), Migraine and Cluster Headaches, Migraine (Pediatric), migraines
Treatment Automated Variable Pressure Insufflation
Clinical Study IdentifierNCT04584762
SponsorNocira, LLC
Last Modified on18 January 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note